First national registry of evolocumab in clinical practice in cardiology units in Spain. The RETOSS-CARDIO study

Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):513-515. doi: 10.1016/j.rec.2019.11.011. Epub 2020 Feb 3.

[Article in English, Spanish]

Authors

Vivencio Barrios¹, Carlos Escobar², Vicente Arrarte³, Cecilia Roldán⁴

Affiliations

¹ Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain. Electronic address: vivenciobarrios@gmail.com.
² Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain.
³ Servicio de Cardiología, Hospital General Universitario de Alicante, Alicante, Spain.
⁴ Departamento Médico, Amgen, Barcelona, Spain.

PMID: 32029367
DOI: 10.1016/j.rec.2019.11.011

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized
Cardiology*
Humans
Registries
Societies, Medical
Spain / epidemiology

Substances

Antibodies, Monoclonal, Humanized
evolocumab